Navigation Links
Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices
Date:12/21/2011

NEW YORK, Dec. 21, 2011 /PRNewswire/ -- Responding to a need for better post-market surveillance of orthopedic devices, the U.S. Food and Drug Administration established the International Consortium of Orthopaedic Registries in October 2010.

As outlined in a Dec. 21 special online supplement in the Journal of Bone and Joint Surgery, ICOR is in the process of developing a collaborative process for improving the safety of orthopedic devices using outcomes registries from the U.S. and other countries. The combined ICOR registries may include data on millions of orthopedic surgical procedures and all implantable devices on the market.

More than 700,000 joint-replacement devices are implanted in patients in the U.S. every year, and this volume is projected to increase twofold for hip-joint replacements and sevenfold for knee-joint replacements, to a total of more than 3 million annually in the next 20 years.

While there have been dramatic advancements in orthopedics, including new devices and improved surgical techniques, the value of many of these devices has not been established using large studies in real-world settings. The FDA chair of the meeting, Danica Marinac-Dabic, MD, and ICOR meeting co-leads, Art Sedrakyan, MD, (Weill Cornell Medical College and the Hospital for Special Surgery) and Elizabeth Paxton (Kaiser Permanente), believe that the consortium will help ameliorate this problem.

Unlike drugs, devices have a different path of approval that may not require the conducting of clinical trials in the United States. Furthermore, adverse outcomes reporting for devices is voluntary, and the resulting data are often incomplete or inaccurate. While there is currently an effort by the American Academy of Orthopedic Surgeons to develop a large national registry, the mid-term follow up will likely take several years or more, says Dr. Sedrakyan, who coordinated the supplement for ICOR and is directing the Patient-Center
'/>"/>

SOURCE Kaiser Permanente; Weill Cornell Medical College
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Avastin(R) Shows Unprecedented Benefits in Colorectal Cancer Patients, Irrespective of K-Ras Gene Mutation
2. Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
3. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
4. Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris
5. Recent Patient Series Demonstrates Spirus Medicals Power Spiral Endoscope Enables Unprecedented Access to GI Tract
6. UHC Launches RxLINKâ„¢, Gives Hospitals Unprecedented Insight Into Pharmaceutical Pricing
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
10. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
11. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DUBLIN , January 15, 2014 Shire plc ... waived the Office of Fair Trading (OFT) approval condition to the ... Incorporated (NASDAQ: VPHM).   As a result of the ... Shire expects to complete the tender offer on January 24, 2014 ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb ... in ambulances and other transport vehicles, an advanced and portable UV ... personnel for the first time. In order to ... these deadly pathogens, West Palm Beach Fire ...
(Date:1/15/2014)... The Cadence Fitness & Health Center has been certified ... Association, a non-profit organization assisting medically integrated health and ... Fitness & Health Center is the only certified fitness ... Chicagoland area. "The certification means the Cadence ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... Loss, Non-Inferiority in Target Vessel Failure and Low Rates of MACE ... ... PARK, Ill., April 22 A study published,in today,s Journal of ... Everolimus Eluting Coronary Stent System,in patients with coronary artery disease resulted ...
... Data For Presentation At ASCO 2008, LONDON ... a wide range of new data at the ... Chicago starting Friday, May,30th. The data cover a ... treatment and supportive care of cancer,patients. At this ...
Cached Medicine Technology:Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 2Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 3Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 4Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 5GlaxoSmithKline Reports Further Progress of Oncology Portfolio 2GlaxoSmithKline Reports Further Progress of Oncology Portfolio 3GlaxoSmithKline Reports Further Progress of Oncology Portfolio 4GlaxoSmithKline Reports Further Progress of Oncology Portfolio 5GlaxoSmithKline Reports Further Progress of Oncology Portfolio 6GlaxoSmithKline Reports Further Progress of Oncology Portfolio 7
(Date:4/17/2014)... PHILADELPHIA The presence of chronic inflammation in ... aggressive, prostate cancer, and this association was found ... levels, according to a study published in ... of the American Association for Cancer Research. , ... some participants of the placebo arm of the ...
(Date:4/17/2014)... PLOS Pathogens , children who live in regions of ... immune response to infection with malaria parasites that may ... and illness and partially control the growth of malaria ... develop future interventions that prevent or mitigate the disease ... 200 million cases of malaria occur worldwide, resulting in ...
(Date:4/17/2014)... McCullers, MD, was recently invited to submit a ... Reviews Microbiology , one of the world,s foremost ... disease specialist, and chair of the Department of ... Center, analyzed the epidemiology and microbiology of co-infections ... well as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... 16, 2014) The cause of neuronal death in ... proposes that neurons may be mistaken for foreign invaders ... to the way autoimmune diseases like type I diabetes, ... The study was published April 16, 2014, in ... likely controversial, idea in Parkinson,s disease; but if true, ...
(Date:4/17/2014)... An international team led by researchers at UC Davis ... plays a key role in cell division, also boosts ... the first time the complex has been shown to ... B1/Cdk1 an excellent target to control cellular energy production, ... was published online today in the journal Developmental ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
... ... help dental practices increase their visibility & conversions online. , ... Oak Brook, IL (PRWEB) September 26, 2009 ... social networking program to help dental and medical practices gain higher visibility online and ...
... Brazilian wandering spider may improve erections, researchers say , ... discovered a novel way to treat erectile dysfunction -- ... bite from the Brazilian wandering spider (Phoneutria nigriventer) causes ... and later lead to impotence, researchers from the United ...
... in everything from problems with California,s hospitals to a perpetual ... the city will find itself deluged not only by smart ... solvers who tackle America,s greatest threats. The annual meeting of ... takes place at the San Diego Convention Center and the ...
... reports high success rate for new test, with results in ... new test can rapidly identify active tuberculosis in people who,ve ... half of all people with active TB, the disease-causing bacterium ... diagnostic tests are needed to help control the spread of ...
... created a new approach that vastly improves the ... organs. Kenneth Longmuir, associate professor of physiology ... & neurobiology, used liposomes, small spheres (less-than 100 ... "packages" for the cancer chemotherapeutic agent doxorubicin, and ...
... SEPT. 25, 2009 Journalists are invited to attend a ... care experts who will review and develop programs that may ... The symposium, which will be held Oct. 8 and 9 ... of Dimes, the American College of Obstetricians and Gynecologists, the ...
Cached Medicine News:Health News:Dental Website Marketing Firm, Officite, Launches Social Networking Program 2Health News:Dental Website Marketing Firm, Officite, Launches Social Networking Program 3Health News:Spider Venom -- The Next Way to Treat Impotence? 2Health News:4,000 numbers crunchers count on San Diego 2Health News:Faster Detection of TB May Be on the Horizon 2Health News:UCI researchers create new strategy for highly selective chemotherapy delivery 2Health News:Experts to review quality improvement programs to prevent preterm birth 2Health News:Experts to review quality improvement programs to prevent preterm birth 3
The Medtronic ULTRAFLEX™ venous cannula provides you with excellent cannula flexibility. This new, unique design provides easy maneuvering during placement and kink resistant flexibility during ...
... The DLP® One-Piece Pediatric Arterial ... in our line of pediatric ... advances over previous models such ... body and patented Flow-Guard™ introducer ...
... CAP® cannulae provides a simple solution ... An innovative combination of aortic perfusion ... the Select CAP® can provide a ... pressure readings on which you can ...
... the vitreoretinal surgeon a temporary tamponade for ... subretinal fluid, dissection of fibro-vascular proliferation and ... Eftiar Decalin liquid is indicated for use ... the retina. It is also indicated as ...
Medicine Products: